领域 | 组别 | 治疗前 | 治疗后 |
躯体功能PF | 治疗组 | 92.17 ± 6.560 | 96.89 ± 4.266a |
对照组 | 92.73 ± 5.001 | 89.84 ± 7.541a | |
角色功能RF | 治疗组 | 91.30 ± 9.885 | 97.78 ± 5.684a |
对照组 | 93.94 ± 8.206 | 86.27 ± 16.910 | |
认知功能CF | 治疗组 | 99.28 ± 3.475 | 100.00 ± 0.000 |
对照组 | 99.24 ± 3.553 | 96.67 ± 6.900 | |
情绪功能EF | 治疗组 | 94.20 ± 11.077 | 100.00 ± 0.000a |
对照组 | 98.86 ± 2.927 | 97.65 ± 3.284 | |
社会功能SF | 治疗组 | 92.75 ± 14.058 | 96.67 ± 9.344 |
对照组 | 90.91 ± 15.195 | 90.20 ± 13.253 | |
疲乏FA | 治疗组 | 24.15 ± 6.402 | 12.59 ± 12.505ab |
对照组 | 21.21 ± 9.643 | 29.41 ± 11.070 | |
疼痛PA | 治疗组 | 4.345 ± 9.014 | 0.00 ± 0.000 |
对照组 | 5.30 ± 15.758 | 7.84 ± 19.648 | |
恶心呕吐NV | 治疗组 | 0.72 ± 3.475 | 2.22 ± 5.864 |
对照组 | 0.00 ± 0.000 | 3.92 ± 7.287 | |
呼吸困难DY | 治疗组 | 27.54 ± 12.918 | 26.67 ± 13.801 |
对照组 | 33.33 ± 10.287 | 31.37 ± 8.085 | |
睡眠障碍SL | 治疗组 | 26.09 ± 19.991 | 8.89 ± 15.258ab |
对照组 | 18.18 ± 26.681 | 33.33 ± 28.868a | |
食欲下降AP | 治疗组 | 1.45 ± 6.950 | 2.22 ± 8.607 |
对照组 | 0.00 ± 0.000 | 21.57 ± 20.211a | |
经济困难FI | 治疗组 | 1.45 ± 6.950 | 2.22 ± 8.607 |
对照组 | 0.00 ± 0.000 | 7.84 ± 14.575a | |
总健康水平GOL | 治疗组 | 77.17 ± 8.782 | 79.44 ± 22.464c |
对照组 | 76.14 ± 12.143 | 67.65 ± 7.146a |